Suzuki Mitsuhiro, Yamada Toshiyuki, Kihara-Negishi Fumiko, Sakurai Takuya, Oikawa Tsuneyuki
Department of Cell Genetics, Sasaki Institute, 2-2 Kanda Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Oncogene. 2003 Nov 27;22(54):8688-98. doi: 10.1038/sj.onc.1207182.
PU.1, a member of the Ets family of transcription factors, is implicated in hematopoietic cell differentiation through its interactions with other transcriptional factors and cofactors. To identify a novel protein(s) binding to PU.1, we carried out affinity purification using a column of Glutathione-Sepharose beads bound to GST-PU.1 fusion protein and isolated several individual proteins using murine erythroleukemia (MEL) cell extracts. Sequence analysis of these proteins revealed that one was MeCP2 a methyl CpG binding protein. GST-pull-down assay and immunoprecipitation assay showed that PU.1 bound directly to MeCP2 via its Ets domain and MeCP2 bound to PU.1 via either its amino terminal domain or trans-repression domain. MeCP2 repressed transcriptional activity of PU.1 on a reporter construct with trimerized PU.1 binding sites. This downregulation was recovered in the presence of histone deacetylase inhibitor, trichostatin A (TSA). MeCP2 was integrated in PU.1-mSin3A-HDAC complex but not in PU.1-CBP complex. Chromatin immunoprecipitation (ChIP) assays showed that PU.1 and MeCP2 were collocated at the PU.1 binding site on the reporter construct and the PU.1 binding site of the intervening sequence 2 (IVS2) region in the intron of the beta-globin gene, which has been proposed to regulate expression of the gene, in undifferentiated MEL cells. The complex disappeared from the region during the course of erythroid differentiation of MEL cells. Our results suggest that MeCP2 acts as a corepressor of PU.1 probably due to facilitating complex formation with mSin3A and HDACs.
PU.1是Ets转录因子家族的成员之一,通过与其他转录因子和辅因子相互作用参与造血细胞分化。为了鉴定与PU.1结合的新型蛋白质,我们使用与GST-PU.1融合蛋白结合的谷胱甘肽-琼脂糖珠柱进行亲和纯化,并使用小鼠红白血病(MEL)细胞提取物分离出几种单个蛋白质。对这些蛋白质的序列分析表明,其中一种是MeCP2,一种甲基CpG结合蛋白。GST下拉试验和免疫沉淀试验表明,PU.1通过其Ets结构域直接与MeCP2结合,而MeCP2通过其氨基末端结构域或反式抑制结构域与PU.1结合。MeCP2抑制了带有三聚化PU.1结合位点的报告基因构建体上PU.1的转录活性。在组蛋白去乙酰化酶抑制剂曲古抑菌素A(TSA)存在的情况下,这种下调得以恢复。MeCP2整合到PU.1-mSin3A-HDAC复合物中,但未整合到PU.1-CBP复合物中。染色质免疫沉淀(ChIP)试验表明,在未分化的MEL细胞中,PU.1和MeCP2共定位于报告基因构建体上的PU.1结合位点以及β-珠蛋白基因内含子中插入序列2(IVS2)区域的PU.1结合位点,该区域被认为可调节基因表达。在MEL细胞红系分化过程中,该复合物从该区域消失。我们的结果表明,MeCP2可能作为PU.1的共抑制因子,这可能是由于它促进了与mSin3A和HDACs的复合物形成。